Clinical trial
A Pilot Study to Assess the Efficacy and Safety of a Novel Device (VIZO Glasses) in the Management of ADHD in Adults
NCT05777785 is registered in ClinicalTrials.gov with VIZO Specs Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study to Assess the Efficacy and Safety of a Novel Device (VIZO Glasses) in the Management of ADHD in Adults
- Lead sponsor
- VIZO Specs Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2022
- Completion date
- March 26, 2023
- Enrollment
- 108 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adhd